Reviva Pharmaceuticals (RVPH) Q1 2023 Earnings

15MayConfirmed
Aug 22
Nov 22
Q4 2022
Q1 2023
-0.38
-0.31
-0.25
-0.18

Details

Expected EPS
-0.32
Actual EPS
-0.3
Surprise EPS
0.02
Surprise Percent
+6.25%

Description

Reviva Pharmaceuticals (RVPH) has reported earnings of -0.3 per share for Q1 2023.

0 Comments

Share your thoughts